Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by WIMALAWANSA, S.J.
Right arrow Articles by MACINTYRE, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WIMALAWANSA, S.J.
Right arrow Articles by MACINTYRE, I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 110, No. 6, 1647-1655, 1987
© 1987 Guarantors of Brain


research-article

THE PRESENCE OF CALCITONIN GENE-RELATED PEPTIDE IN HUMAN CEREBROSPINAL FLUID

S.J. WIMALAWANSA and I. MACINTYRE

From the Endocrine Unit, Department of Chemical Pathology, Royal Postgraduate Medical School London

Correspondence to: DR S.J. Wimalawansa, Endocrine Unit, Department of Chemical Pathology, Royal Postgraduate Medical School, Du Cane Road, London, W12OHs, UK.

This study demonstrates the presence of calcitonin gene-related peptide (CGRP) in human cerebrospinal fluid (CSF) using specific and sensitive radioimmunoassay, together with gel-permeation and high performance liquid chromatography (HPLC). The median immunoreactive CGRP (i-CGRP) level from 158 CSF specimens was 8.0pmol/l, as measured with an antiserum recognizing the whole molecule of CGRP (CC-2/1) and 12.0 pmol/1 with an antiserum recognizing the C-terminal region of CGRP (CG-39).

CSF samples with high protein concentration (>0.6g/l) had a median level of i-CGRP of 18.4pmol/l when measured with antiserum CC-2/1 and 23.0pmol/l with CG-39, while samples with ‘normal’ protein concentrations (<0.6 g/1) had much lower values, with median levels of 7.0 and 11.0 pmol/l, with the two antisera, respectively. Gel-permeation chromatography and HPLC studies revealed multiple peaks of i-CGRP, consistent with forms with different molecular weights. However, on HPLC, the major peak of i-CGRP corresponded to the elution position of the synthetic hCGRP(1–37) and was able to bind to a CGRP specific receptor preparation suggesting that it may be biologically active.

Received January 15, 1987. Revised March 26, 1987. Accepted April 14, 1987.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.